Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

China Pharma (CPHI)

China Pharma Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:CPHI
DateTimeSourceHeadlineSymbolCompany
08/05/202421:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
23/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
23/02/202421:05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
15/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:CPHIChina Pharma Holdings Inc
08/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
06/02/202421:16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CPHIChina Pharma Holdings Inc
26/01/202422:04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:CPHIChina Pharma Holdings Inc
26/01/202422:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
12/01/202421:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:CPHIChina Pharma Holdings Inc
12/01/202419:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:CPHIChina Pharma Holdings Inc
21/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
19/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
29/11/202313:00PR Newswire (US)China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceAMEX:CPHIChina Pharma Holdings Inc
13/11/202321:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
07/11/202321:05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:CPHIChina Pharma Holdings Inc
27/10/202321:06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:CPHIChina Pharma Holdings Inc
19/10/202321:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
03/10/202321:05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
14/08/202320:40Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
09/08/202313:30PR Newswire (US)China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic DrugsAMEX:CPHIChina Pharma Holdings Inc
12/05/202321:07Edgar (US Regulatory)Quarterly Report (10-q)AMEX:CPHIChina Pharma Holdings Inc
30/03/202321:56Edgar (US Regulatory)Annual Report (10-k)AMEX:CPHIChina Pharma Holdings Inc
29/03/202321:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
09/03/202321:07Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:CPHIChina Pharma Holdings Inc
09/03/202321:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:CPHIChina Pharma Holdings Inc
24/02/202321:07Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
24/02/202321:05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
30/12/202221:06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
28/12/202213:00PR Newswire (US)China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective MaskAMEX:CPHIChina Pharma Holdings Inc
15/12/202213:00PR Newswire (US)China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19AMEX:CPHIChina Pharma Holdings Inc
 Showing the most relevant articles for your search:AMEX:CPHI

Your Recent History

Delayed Upgrade Clock